Teva Pharmaceutical Industries (NYSE:TEVA) has seen its stock move steadily over the past month, gaining about 5%. Investors ...

Key Points Israel-based Phoenix Financial acquired more than 3.5 million additional shares of Teva Pharmaceuticals for an estimated $62.1 million in the third quarter. Post-transaction, the fund ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this ...

This football season, Teva is increasing education around tardive dyskinesia (TD) by launching 'The Other TD' campaignTD is a chronic movement disorder impacting one in four people who take certain pr ...

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of ...

This football season, Teva is increasing education around tardive dyskinesia (TD) by launching ‘The Other TD’ campaign TD is a chronic movement ...

Explore how Teva Pharmaceutical (NYSE:TEVA) strengthens its global presence and influence in Healthcare Stocks worldwide.

Harel Insurance Investments & Financial Services Ltd. increased its Teva holding to 6.84% of its reportable U.S. equity ...

Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR asthma inhalers, ...

Teva and Prestige announce a license and supply agreement for the commercialization of Prestige's Tuznue®, a biosimilar to Herceptin® (trastuzumab) Tuznue® received European Commission (EC) marketing ...

Teva Pharmaceuticals and Medincell recently announced that the FDA has approved UZEDY® (risperidone), a once-monthly ...

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is one of the 11 Dirt Cheap Stocks to Buy According to Analysts.